29.08
전일 마감가:
$29.35
열려 있는:
$29.31
하루 거래량:
3.21M
Relative Volume:
1.04
시가총액:
$4.41B
수익:
$3.24B
순이익/손실:
$304.90M
주가수익비율:
13.98
EPS:
2.08
순현금흐름:
$156.70M
1주 성능:
-12.85%
1개월 성능:
-16.00%
6개월 성능:
-37.18%
1년 성능:
-54.71%
Bruker Corp Stock (BRKR) Company Profile
명칭
Bruker Corp
전화
978663-3660
주소
40 MANNING RD, BILLERICA, MA
BRKR을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
BRKR
Bruker Corp
|
29.07 | 5.04B | 3.24B | 304.90M | 156.70M | 2.08 |
![]()
ABT
Abbott Laboratories
|
133.35 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
107.73 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
![]()
SYK
Stryker Corp
|
393.43 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
93.08 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
![]()
EW
Edwards Lifesciences Corp
|
81.29 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
2024-12-19 | 개시 | Guggenheim | Buy |
2024-12-10 | 개시 | UBS | Neutral |
2024-12-05 | 업그레이드 | Goldman | Sell → Neutral |
2024-10-15 | 개시 | Barclays | Overweight |
2024-09-30 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
2024-08-28 | 개시 | Wells Fargo | Overweight |
2024-06-03 | 재개 | Jefferies | Buy |
2024-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
2023-12-19 | 개시 | Wells Fargo | Equal Weight |
2023-12-13 | 개시 | Wolfe Research | Outperform |
2022-10-21 | 개시 | UBS | Buy |
2022-08-22 | 업그레이드 | Citigroup | Neutral → Buy |
2021-10-15 | 재개 | Cowen | Market Perform |
2021-06-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
2021-02-05 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2020-12-02 | 개시 | Goldman | Sell |
2020-11-16 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
2020-05-01 | 다운그레이드 | Cleveland Research | Buy → Neutral |
2020-04-02 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
2020-04-01 | 다운그레이드 | Needham | Strong Buy → Hold |
2020-03-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
2020-01-08 | 개시 | Wells Fargo | Overweight |
2020-01-07 | 개시 | Citigroup | Buy |
2019-11-15 | 개시 | Stifel | Hold |
2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2019-07-15 | 업그레이드 | Goldman | Sell → Neutral |
2019-06-24 | 재확인 | Needham | Strong Buy |
2019-06-21 | 재확인 | BofA/Merrill | Neutral |
2019-05-30 | 개시 | Wolfe Research | Peer Perform |
2019-05-06 | 재확인 | Needham | Strong Buy |
2019-05-03 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
2019-05-03 | 업그레이드 | UBS | Sell → Neutral |
2019-04-12 | 업그레이드 | Deutsche Bank | Hold → Buy |
2019-02-12 | 재확인 | BTIG Research | Buy |
2019-01-03 | 개시 | Needham | Strong Buy |
모두보기
Bruker Corp 주식(BRKR)의 최신 뉴스
Bruker Falls After Public Offering of Mandatory Convertible Preferred Stock - 富途牛牛
Crude Oil Falls Over 2%; Campbell's Earnings Top Estimates - Benzinga
Bruker stock falls after $600 million convertible preferred stock offering - Investing.com
Sector ETF performance correlation with Bruker Corporation2025 Trading Volume Trends & Comprehensive Market Scan Insights - Newser
Bruker Corporation stock hits 52-week low at 29.68 USD - Investing.com
Analyzing drawdowns of Bruker Corporation with statistical toolsJuly 2025 EndofMonth & Low Risk Entry Point Tips - Newser
Bruker Shares Plummet as Company Announces $600 Million Public Offering - AInvest
Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
Smart tools for monitoring Bruker Corporation’s price action2025 Market Trends & Real-Time Buy Zone Alerts - Newser
S&P 500 Futures Up in Premarket Trading; Bruker, Commercial Metals Lag - Barron's
Ranking Bruker Corporation among high performing stocks via toolsEntry Point & Verified Short-Term Plans - Newser
Key resistance and support levels for Bruker CorporationJuly 2025 WrapUp & Entry Point Strategy Guides - Newser
Bruker Launches $600 Million Mandatory Convertible Preferred Stock Offering - 富途牛牛
Will Bruker Corporation outperform during market ralliesOil Prices & Weekly Setup with High ROI Potential - khodrobank.com
Bruker’s $600M Preferred Stock Offering: Balancing Deleveraging Gains and Dilution Risks - AInvest
Bruker Corp. (BRKR) Dismal Q2 Earnings Weighs On Sentiment - MSN
Bruker launches $600 million convertible preferred stock offering - Investing.com
Bruker Announces Public Offering of $600 Million of Mandatory Convertible Preferred Stock - MarketScreener
$600 Million Stock Offering: Bruker Corporation Launches Major Convertible Preferred Stock Sale to Clear Debt - Stock Titan
Multi factor analysis applied to Bruker CorporationWeekly Earnings Recap & Technical Entry and Exit Alerts - Newser
Can trapped investors hope for a rebound in Bruker Corporation2025 Price Action Summary & AI Based Trade Execution Alerts - Newser
Is Bruker Corporation stock ready for a breakoutDollar Strength & Stepwise Entry and Exit Trade Signals - Newser
Can Bruker Corporation sustain earnings growthMarket Sentiment Review & Safe Entry Point Identification - khodrobank.com
Gainers Report: Can Bruker Corporation stock double in the next yearStop Loss & Verified High Yield Trade Plans - khodrobank.com
Institutional scanner results for Bruker CorporationTrade Exit Summary & Capital Efficient Trading Techniques - Newser
Published on: 2025-09-01 13:00:22 - Newser
Metrology Sensor | Bruker Alicona | Aug 2025 - Photonics Spectra
Is it too late to sell Bruker CorporationPortfolio Gains Report & Safe Swing Trade Setups - Newser
Bruker Corporation stock outlook for YEARWeekly Trend Recap & Verified Short-Term Plans - Newser
Should We Be Cautious About Bruker Corporation's (NASDAQ:BRKR) ROE Of 4.0%? - ca.finance.yahoo.com
Regression analysis insights on Bruker Corporation performanceEarnings Overview Summary & Free High Return Stock Watch Alerts - Newser
Volatility clustering patterns for Bruker Corporation2025 Institutional Moves & Verified Swing Trading Watchlists - Newser
Developing predictive dashboards with Bruker Corporation data2025 Key Lessons & AI Based Buy/Sell Signal Reports - Newser
Comparing Bruker Corporation in custom built stock radarsJuly 2025 Gainers & Free Safe Entry Trade Signal Reports - Newser
How to read the order book for Bruker Corporation2025 Sector Review & Safe Investment Capital Preservation Plans - Newser
Earnings visualization tools for Bruker CorporationJuly 2025 Final Week & Community Consensus Stock Picks - Newser
How to integrate Bruker Corporation into portfolio analysis toolsJuly 2025 Closing Moves & Target Return Focused Stock Picks - Newser
Bruker Corp (BRKR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Bruker Corp 주식 (BRKR) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
ORNELL JOHN A | Director |
May 13 '25 |
Option Exercise |
18.15 |
5,000 |
90,750 |
31,445 |
LINTON WILLIAM A | Director |
Apr 22 '25 |
Option Exercise |
24.00 |
10,000 |
240,000 |
58,723 |
Bures Thomas | Chief Accounting Officer |
Mar 10 '25 |
Buy |
47.40 |
500 |
23,698 |
3,472 |
LAUKIEN FRANK H | PRESIDENT & CEO |
Feb 18 '25 |
Buy |
50.92 |
20,000 |
1,018,330 |
38,459,563 |
PACKER RICHARD A | Director |
Dec 02 '24 |
Option Exercise |
19.12 |
10,000 |
191,200 |
84,254 |
PACKER RICHARD A | Director |
Dec 02 '24 |
Sale |
57.82 |
3,350 |
193,683 |
80,904 |
자본화:
|
볼륨(24시간):